Literature DB >> 24387718

Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity.

Takashi Fujibayashi1, Susumu Sugai, Nobuyuki Miyasaka, Yoshio Hayashi, Kazuo Tsubota.   

Abstract

Abstract The Japanese criteria for diagnosing Sjögren's syndrome (SS) were revised in 1999, and consist of four major areas: histopathology, oral examination, ocular examination, and serological examination. A diagnosis of SS can be made when the patient meets at least two of these four criteria. This report describes how the revised Japanese criteria were established. After the publication of the revised Japanese criteria (1999), a research study which focused on evaluating its availability and validity was carried out in 2001 using funds from Grant-in-Aids for Scientific Research supported by the Japan Society for the Promotion of Science. The availability of the revised criteria was investigated by a questionnaire study through the Japanese Medical Society for Sjögren's Syndrome, and the use of the revised criteria for diagnosing SS in these medical facilities was found to be 76%. To evaluate the validity of the revised criteria, the records of 900 patients, including SS patients and non-SS controls, from 54 clinical centers were registered and analyzed to calculate the accuracy of the criteria. The revised Japanese criteria were found to have 96.0% sensitivity, 90.5% specificity, and 94.5% accuracy for diagnosing SS.

Entities:  

Year:  2004        PMID: 24387718     DOI: 10.3109/s10165-004-0338-x

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  70 in total

1.  Massive calcinosis cutis associated with primary Sjögren's syndrome.

Authors:  Yumi Tsuchida; Shuji Sumitomo; Keishi Fujio; Kazuhiko Yamamoto
Journal:  BMJ Case Rep       Date:  2016-02-04

2.  Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome.

Authors:  Y Naito; I Matsumoto; E Wakamatsu; D Goto; S Ito; A Tsutsumi; T Sumida
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

3.  Efficacy prediction of cevimeline in patients with Sjögren's syndrome.

Authors:  Hiroyuki Yamada; Yoichi Nakagawa; Ei Wakamatsu; Takayuki Sumida; Shigeo Yamachika; Yoshiaki Nomura; Kenji Mishima; Ichiro Saito
Journal:  Clin Rheumatol       Date:  2007-01-13       Impact factor: 2.980

4.  Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant.

Authors:  Takao Nagashima; Motoaki Hoshino; Shin Shimoji; Noritsugu Morino; Takeshi Kamimura; Hitoaki Okazaki; Seiji Minota
Journal:  Rheumatol Int       Date:  2008-11-29       Impact factor: 2.631

5.  Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome.

Authors:  Tetsutaro Kitagawa; Koichi Shibasaki; Shuji Toya
Journal:  Clin Rheumatol       Date:  2011-06-14       Impact factor: 2.980

6.  M3 muscarinic acetylcholine receptor-reactive Th17 cells in primary Sjögren's syndrome.

Authors:  Saori Abe; Hiroto Tsuboi; Hanae Kudo; Hiromitsu Asashima; Yuko Ono; Fumika Honda; Hiroyuki Takahashi; Mizuki Yagishita; Shinya Hagiwara; Yuya Kondo; Isao Matsumoto; Takayuki Sumida
Journal:  JCI Insight       Date:  2020-08-06

Review 7.  [Ultrasound diagnostics in Sjögren's syndrome].

Authors:  V S Schäfer; W A Schmidt
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

8.  Performance of the 2016 ACR-EULAR classification criteria for primary Sjogren's syndrome in a Korean cohort.

Authors:  Jennifer Lee; Jung Hee Koh; Ji-Won Kim; Yoon-Kyoung Sung; Shin-Seok Lee; Jung Yoon Choe; Seung-Cheol Shim; Hyun-Sook Kim; Hae-Rim Kim; Ji-Min Kim; Sung Ryul Kwon; Hyun-Ok Kim; Kichul Shin; Chang Hoon Lee; So-Hyang Chung; Seung-Ki Kwok; Ji Hyeon Ju; Sung-Hwan Park
Journal:  Rheumatol Int       Date:  2018-07-20       Impact factor: 2.631

9.  Impaired Junctions and Invaded Macrophages in Oral Epithelia With Oral Pain.

Authors:  Reiko U Yoshimoto; Reona Aijima; Yukiko Ohyama; Junko Yoshizumi; Tomoko Kitsuki; Yasuyoshi Ohsaki; Ai-Lin Cao; Atsushi Danjo; Yoshio Yamashita; Tamotsu Kiyoshima; Mizuho A Kido
Journal:  J Histochem Cytochem       Date:  2018-11-19       Impact factor: 2.479

Review 10.  A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease.

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Mikiko Ohara; Chisako Suzuki; Yasuyoshi Naishiro; Hiroyuki Yamamoto; Yasuhisa Shinomura; Kohzoh Imai
Journal:  Mod Rheumatol       Date:  2006-12-20       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.